Pub. Date : 2017 Nov
PMID : 28829213
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | INTRODUCTION: Trelagliptin is a novel, long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor approved for the treatment of type 2 diabetes mellitus (T2DM) in japan. | trelagliptin | dipeptidyl peptidase 4 | Homo sapiens |
| 2 | INTRODUCTION: Trelagliptin is a novel, long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor approved for the treatment of type 2 diabetes mellitus (T2DM) in japan. | trelagliptin | dipeptidyl peptidase 4 | Homo sapiens |
| 3 | An advantage of trelagliptin over existing once-daily DPP-4 inhibitors is the decrease of dosing frequency, rather than once-daily. | trelagliptin | dipeptidyl peptidase 4 | Homo sapiens |